Category: Harvard affiliates
July 27, 2014- Interviewed by Steven E. Greer, MD
Ben Sommers, MD PhD, from the Harvard School of Public Health has a new article in the NEJM that attempts to quantify the total number of uninsured people in the country, and map it out temporally to show whether the newly implemented Obamacare law is working as intended.
October 19, 2014- Interviewed by Steven E. Greer, MD
Alessio Fasano, MD of Harvard discusses his 10-year-long study in children testing whether the delayed introduction of gluten into the diet reduced the eventual incidence of celiac disease. Dr. Fasano is most responsible for raising awareness of gluten intolerance after his 2003 NEJM and Archives of Internal Medicine papers were published.
Part 1: Medicaid primer
Part 2: State spending on Medicaid
Part 3: Impact of Medicaid expansion to hospitals, states, and mortality
Part 4: Efforts by individual states to reform Medicaid away from fee-for-service
Part 5: Will other states adopt bundled payment plans for Medicaid and stop fee-for-service?
Part 6: What does the ACA ObamaCare law mean for Medicaid?
Part 7: Will individual state reforms of Medicaid lead to a more global reform of American healthcare?
Part 8: Impact the healthcare companies
Part 9: The outcome of the election and Medicaid/ACA law
I emailed earlier today a leading HIV researcher, Monica Gandhi MD, MPH from Read more »
Interviewed by Steven E. Greer, MD
Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General Hospital and also Chairman of the Massachusetts Medical Society’s Committee on Preparedness, discusses how his hospital prepares and trains for the event of chemical and nuclear (dirty bomb) attacks.
Dr. Berwick, former Director of CMS and former President and CEO of IHI, discusses the percentage of waste in the American Healthcare System. He also mentions the new proposals by nine specialties recommending that 45 procedures and tests be performed less often as they are almost always unnecessary.
March 8, 2013 By Steven E. Greer, MD
We interviewed three of the oncologists and industry executives who spoke at the Damon Runyon Cancer Research Foundation in Cambridge, Massachusetts in March. They were:
- Richard B. Gaynor, MD, Chair, Accelerating Cancer Cures; Vice President, Cancer Research/Clinical Investigation, Eli Lilly
- Michael J. Vasconcelles, MD, Senior Vice President, Oncology Clinical Development Millennium; The Takeda Oncology Company
- Catherine Wu, MD, Dana-Farber Cancer Institute
The first topic of discussion was Read more »